BioProcess Technology Consultants, Inc. (BPTC), a strategic and regulatory consulting company for the global biopharma industry, has acquired CTD Quality Consulting, LLC, specializing in regulatory submissions and strategy, GxP compliance training, and inspection readiness for pharma, biopharma, and medical device companies.
 
“BioProcess Technology Consultants is the ideal company to continue offering the highest level of quality and regulatory writing and training services that I have strived to build over the years. I wish them continued success in building this business and am pleased to continue as an advisor to them,” said Michelle H. Foster, Ph.D., founder and principal of CTD Quality Consulting.
 
With the acquisition, BPTC has also formed a new division, advanceONE, consolidating the CMC quality, regulatory, and compliance services of both companies into a suite of comprehensive services for pharma, biopharma, and medical device clients. According to Sheila Magil, Ph.D., senior consultant and quality expert at BPTC, “advanceONE will significantly expand the quality, regulatory, and compliance services we offer our clients throughout the entire product lifecycle.”
 
Also, Alfred R. Doig, Jr., M.S., has been appointed manager of advanceONE. Mr. Doig has more than 30 years of business development and project management experience in the life sciences and previously directed the publishing and editorial activities at Drug & Market Development Reports and Insight Pharma Reports